Skip to content

Surgery Partners, Inc. SGRY Purchases of equity securities

Purchases of equity securities at other companies

PACS Group logo
PACS GroupPACS
$20.05M

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.99B-49.1%

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireEquityMethodInvestments.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s purchases of equity securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s purchases of equity securities?
Surgery Partners, Inc. (SGRY) reported purchases of equity securities of $0 in Q1 2026.
How has Surgery Partners, Inc.'s purchases of equity securities changed year-over-year?
Surgery Partners, Inc.'s purchases of equity securities decreased by 100.0% year-over-year, from $3.8M to $0.
What does purchases of equity securities mean?
Cash spent purchasing equity securities for the investment portfolio.